Journey Medical Corp（DERM）の株価予測DERMJourney Medical Corp

Alphio's DERM stock price prediction model matches the current Journey Medical Corp tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $4.26 (-0.83%). The 1-week path is $4.32 (+0.41%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Journey Medical Corp (DERM) is a good buy right now due to its recent strong earnings growth, with a reported revenue of $18.5 million in Q2 2026, a 23% increase year-over-year, and a significant reduction in net loss to $300,000, or $0.01 per share. The current price of $4.79 is well below the analyst price target of $15, indicating substantial upside potential. However, the RSI is at 33.735, suggesting that the stock is currently oversold, which could present a buying opportunity. The main risk is the forward P/E ratio of 20.70, indicating that the stock may be overvalued if earnings do not improve as expected.

Journey Medical Corp (DERM) last closed at $4.3000002, losing -9.09%. These facts feed the 1-day and 1-week DERM price prediction above.